Procysbi Available in Wales

Following a decision by the ‘All Wales Therapeutics and Toxicology Centre’ Procysbi will now become routinely available in the NHS across Wales to treat cystinosis. We took part in the appraisal process last year (December 2021) in partnership with Metabolic Support UK and we’re very pleased that this is the outcome, you can find out more at the link below.

https://awttc.nhs.wales/accessing-medicines/medicine-recommendations/mercaptamine-bitartrate-procysbi1/

Procysbi is an alternative to Cystagon, it contains the same active ingredient, cysteamine, but it is a delayed-release formulation meaning it is usually taken twice a day (verses four times a day for Cystagon), which has the potential to reduce side effects and create a more stable white cell cystine level. More information about Procysbi can be found at https://www.ema.europa.eu/en/medicines/human/EPAR/procysbi.
.

Comments are closed.

Procysbi Available in Wales Following a decision by the ‘All Wales Therapeutics and Toxicology Centre’ Procysbi [...] Read more...
Latest News and Updates Webinar – 27th November 2021 Please join us on Saturday, 27th November at 2pm for our ‘Latest News and Updates’ [...] Read more...
Cystinosis Comic Book Series by Artist Kevin McCalla The Cystinosis Research Network in the US has teamed up with Kevin McCalla, a young artist who [...] Read more...
Please Subscribe to Our New Mailing List We are very excited to launch our new mailing list! By signing up for free at the link below [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday